Klemens Budde

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Concepts & Ideas

Anatomy

Kidney

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Krämer Stephanie; Binder Eva; Loof Tanja; Wang-Rosenke Yingrui; Martini Sebastian; Khadzhynov Dmytro; Budde Klemens; Neumayer Hans-H; Peters Harm
The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
Lachmann Nils; Terasaki Paul I; Budde Klemens; Liefeldt Lutz; Kahl Andreas; Reinke Petra; Pratschke Johann; Rudolph Birgit; Schmidt Danilo; Salama Abdulgabar; Schönemann Constanze
Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
Fischer T; Filimonow S; Rudolph J; Morgera S; Budde K; Slowinski T; Ebeling V; Taymoorian K; Giessing M; Thomas A
Arrival time parametric imaging: a new ultrasound technique for quantifying perfusion of kidney grafts.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Klemens Budde (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Krämer Stephanie; Binder Eva; Loof Tanja; Wang-Rosenke Yingrui; Martini Sebastian; Khadzhynov Dmytro; Budde Klemens; Neumayer Hans-H; Peters Harm
The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
American journal of physiology. Renal physiology 2009;297(1):F218-27.
2009: Lachmann Nils; Terasaki Paul I; Budde Klemens; Liefeldt Lutz; Kahl Andreas; Reinke Petra; Pratschke Johann; Rudolph Birgit; Schmidt Danilo; Salama Abdulgabar; Schönemann Constanze
Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
Transplantation 2009;87(10):1505-13.
2008: Fischer T; Filimonow S; Rudolph J; Morgera S; Budde K; Slowinski T; Ebeling V; Taymoorian K; Giessing M; Thomas A
Arrival time parametric imaging: a new ultrasound technique for quantifying perfusion of kidney grafts.
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2008;29(4):418-23.
2008: Giessing Markus; Fuller Florian; Tuellmann Max; Liefeld Lutz; Slowinski Torsten; Budde Klemens; Loening Stefan A
Attitude to nephrolithiasis in the potential living kidney donor: a survey of the German kidney transplant centers and review of the literature.
Clinical transplantation 2008;22(4):476-83.
2008: Giessing Markus; Deger Serdar; Roigas Jan; Schnorr Dietmar; Fuller Florian; Liefeldt Lutz; Budde Klemens; Neumayer Hans-Hellmut; Loening Stefan A
Cross-over kidney transplantation with simultaneous laparoscopic living donor nephrectomy: initial experience.
European urology 2008;53(5):1074-8.
2008: Böhler Torsten; Nolting Jochen; Gurragchaa Purevtseren; Lupescu Adrian; Neumayer Hans-H; Budde Klemens; Kamar Nassim; Klupp Jochen
Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activation and proliferation.
Transplant immunology 2008;18(4):319-23.
2008: Krämer Stephanie; Wang-Rosenke Yingrui; Scholl Valeska; Binder Eva; Loof Tanja; Khadzhynov Dmytro; Kawachi Hiroshi; Shimizu Fujio; Diekmann Fritz; Budde Klemens; Neumayer Hans-H; Peters Harm
Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
American journal of physiology. Renal physiology 2008;294(2):F440-9.
2008: Diekmann Fritz; Budde Klemens; Slowinski Torsten; Oppenheimer Federico; Fritsche Lutz; Neumayer Hans H; Campistol Josep M
Conversion to sirolimus for chronic allograft dysfunction: long-term results confirm predictive value of proteinuria.
Transplant international : official journal of the European Society for Organ Transplantation 2008;21(2):152-5.
2008: Budde Klemens; Glander Petra
Pharmacokinetic principles of immunosuppressive drugs.
Annals of transplantation : quarterly of the Polish Transplantation Society 2008;13(3):5-10.
2007: Budde Klemens; Liefeldt Lutz; Slowinski Torsten; Glander Petra
No evidence for a relationship between infiltrates in renal protocol biopsies and outcome.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(11):2637-8; author reply 2639-40.
2007: Westhoff Timm H; Schmidt Sven; Glander Petra; Liefeld Lutz; Martini Sebastian; Offermann Gerd; Neumayer Hans H; Zidek Walter; van der Giet Markus; Budde Klemens
The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(8):2354-8.
2007: Budde Klemens; Tedesco-Silva Helio; Pestana Jose Medina; Glander Petra; Neumayer Hans-H; Felipe Claudia Rosso; Machado Paula Pinheiro; Sechaud Romain; Schmouder Robert
Enteric-coated mycophenolate sodium provides higher mycophenolic acid predose levels compared with mycophenolate mofetil: implications for therapeutic drug monitoring.
Therapeutic drug monitoring 2007;29(3):381-4.
2007: Martini Sebastian; Krämer Stephanie; Loof Tanja; Wang-Rosenke Yingrui; Daig Ute; Budde Klemens; Neumayer Hans-H; Peters Harm
S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
American journal of physiology. Renal physiology 2007;292(6):F1761-70.
2007: Giessing Markus; Fuller Tom Florian; Tuellmann Max; Slowinski Torsten; Budde Klemens; Liefeldt Lutz
Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: state of the art and future developments.
World journal of urology 2007;25(3):325-32.
2007: Budde K; Bauer S; Hambach P; Hahn U; Röblitz H; Mai I; Diekmann F; Neumayer H-H; Glander P
Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(4):888-98.
2007: Martini Sebastian; Peters Harm; Böhler Torsten; Budde Klemens
Current perspectives on FTY720.
Expert opinion on investigational drugs 2007;16(4):505-18.
2007: Budde K; Bosmans J L; Sennesael J; Zeier M; Pisarski P; Schütz M; Fischer W; Neumayer H H; Glander P
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.
Clinical nephrology 2007;67(3):164-75.
2007: Budde Klemens; Glander Petra; Krämer Bernhard K; Fischer Wolfgang; Hoffmann Ute; Bauer Steffen; Grohmann Jana; Neumayer Hans-Hellmut; Arns Wolfgang
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
Transplantation 2007;83(4):417-24.
2007: Böhler Torsten; Nolting Jochen; Kamar Nassim; Gurragchaa Purevtseren; Reisener Kathrin; Glander Petra; Neumayer Hans-H; Budde Klemens; Klupp Jochen
Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans.
Therapeutic drug monitoring 2007;29(1):77-86.
2007: Pietruck Frank; Budde Klemens; Salvadori Maurizio; Sollinger Hans; Bourbigot Bernard; Gentil Miguel Angel; Oppenheimer Frederic
Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.
Clinical transplantation 2007;21(1):117-25.
2007: Böhler Torsten; Schütz Manuela; Budde Klemens; Neumayer Hans-H; Waiser Johannes
Differential effects of single dose FTY720 on CD62L+ B-cells in stable renal allograft recipients.
International immunopharmacology 2007;7(1):88-95.
2007: Bamberg Christian; Diekmann Fritz; Haase Michael; Budde Klemens; Hocher Berthold; Halle Horst; Hartung John
Pregnancy on intensified hemodialysis: fetal surveillance and perinatal outcome.
Fetal diagnosis and therapy 2007;22(4):289-93.
2006: Nashan B; Suwelack B; Ivens K; Arns W; Lhotta K; Bourbigot B; Budde K; Fischer W; Pietruck F;
Conversion to enteric-coated mycophenolate sodium from various doses of mycophenolate mofetil: results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine.
Transplantation proceedings 2006;38(9):2856-9.
2006: Fischer Thomas; Filimonow Sergej; Dieckhöfer Jan; Slowinski Torsten; Mühler Matthias; Lembcke Alexander; Budde Klemens; Neumayer Hans-H; Ebeling Volker; Giessing Markus; Thomas Anke; Morgera Stanislao
Improved diagnosis of early kidney allograft dysfunction by ultrasound with echo enhancer--a new method for the diagnosis of renal perfusion.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(10):2921-9.
2006: Haase Michael; Morgera Stanislao; Bamberg Christian; Halle Horst; Martini Sebastian; Dragun Duska; Neumayer Hans-H; Budde Klemens
Successful pregnancies in dialysis patients including those suffering from cystinosis and familial Mediterranean fever.
Journal of nephrology 2006;19(5):677-81.
2006: Kamar N; Glander P; Nolting J; Böhler T; Hambach P; Liefeldt L; Neumayer H-H; Klupp J; Budde K
Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation.
Transplantation proceedings 2006;38(7):2292-4.
2006: Budde K; Knoll G; Curtis J; Chan L; Pohanka E; Gentil M; Seifu Y; Marrast A C; Neumayer H H;
Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).
Clinical nephrology 2006;66(2):103-11.
2006: Waiser Johannes; Schneider Michael; Eljazyfer Sara; Slowinski Torsten; Glander Petra; Einecke Gunilla; Budde Klemens; Neumayer Hans-Hellmut; Böhler Torsten
Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine A.
Clinical immunology (Orlando, Fla.) 2006;119(1):59-66.
2006: Fleiner Franca; Fritsche Lutz; Glander Petra; Neumayer Hans-H; Budde Klemens
Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?
Transplantation 2006;81(5):655-9.
2006: Waiser Johannes; Dell Kerstin; Kreutzkamp Jan; Böhler Torsten; Budde Klemens; Peters Harm; Neumayer Hans-Hellmut
FK506, transforming growth factor-beta1 and mesangial matrix synthesis: parallels and differences compared with cyclosporine A.
Cytokine 2006;33(2):59-65.
2006: Budde K; Giessing M; Liefeldt L; Neumayer H-H; Glander P
[Modern immunosuppression following renal transplantation. Standard or tailor made?]
Der Urologe. Ausg. A 2006;45(1):9-17.
2006: Fischer T; Ebeling V; Giessing M; Mühler M; Filimonow S; Dieckhöfer J; Lembcke A; Rudolph J; Morgera S; Budde K; Hamm B; Thomas A
[A new method for standardized diagnosis following renal transplantation. Ultrasound with contrast enhancement]
Der Urologe. Ausg. A 2006;45(1):38-45.
2006: Giessing M; Fuller T F; Deger S; Roigas J; Tüllmann M; Liefeldt L; Budde K; Fischer T; Winkelmann B; Schnorr D; Loening S A
[Ten years of laparoscopic living kidney donation. From an extravagant to a routine procedure]
Der Urologe. Ausg. A 2006;45(1):46-52.
2006: Budde Klemens; Schütz Manuela; Glander Petra; Peters Harm; Waiser Johannes; Liefeldt Lutz; Neumayer Hans-H; Böhler Torsten
FTY720 (fingolimod) in renal transplantation.
Clinical transplantation 2006;20 Suppl 17():17-24.
2005: Fischer Thomas; Dieckhöfer Jan; Mühler Matthias; Lembcke Alexander; Morgera Stanislao; Budde Klemens; Neumayer Hans-Helmuth; Ebeling Volko; Thomas Anke; Filimonow Serjei
The use of contrast-enhanced US in renal transplant: first results and potential clinical benefit.
European radiology 2005;15 Suppl 5():E109-16.
2005: Skerjanec Andrej; Tedesco Helio; Neumayer Hans-H; Cole Edward; Budde Klemens; Hsu Chyi-Hung; Schmouder Robert
FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship.
Journal of clinical pharmacology 2005;45(11):1268-78.
2005: Haase Michael; Morgera Stanislao; Bamberg Christian; Halle Horst; Martini Sebastian; Hocher Berthold; Diekmann Fritz; Dragun Duska; Peters Harm; Neumayer Hans-H; Budde Klemens
A systematic approach to managing pregnant dialysis patients--the importance of an intensified haemodiafiltration protocol.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(11):2537-42.
2005: Liefeldt L; Giessing M; Budde K; Neumayer H-H
[Contraindications to living donor kidney transplantation]
Deutsche medizinische Wochenschrift (1946) 2005;130(36):2039-42.
2005: Budde Klemens; Lehne Gustav; Winkler Michael; Renders Lutz; Lison Arno; Fritsche Lutz; Soulillou Jean-Paul; Fauchald Per; Neumayer Hans-Hellmut; Dantal Jaques;
Influence of everolimus on steady-state pharmacokinetics of cyclosporine in maintenance renal transplant patients.
Journal of clinical pharmacology 2005;45(7):781-91.
2005: Einecke Gunilla; Schütz Manuela; Mai Ingrid; Fritsche Lutz; Giessing Markus; Glander Petra; Neumayer Hans-H; Budde Klemens
Limitations of C2 monitoring in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(7):1463-70.
2005: Fleiner F; Budde K; Dragun D; Hartmann M; Neumayer H H; Fritsche L
Differences in reporting of acute rejections between American and European publications of large immunosuppressive trials impair comparability of study results.
Transplantation proceedings 2005;37(5):2048-50.
2005: Giessing M; Reuter S; Deger S; Tüllmann M; Hirte I; Budde K; Fritsche L; Slowinski T; Dragun D; Neumayer H H; Loening S A; Schönberger B
Laparoscopic versus open donor nephrectomy in Germany: impact on donor health-related quality of life and willingness to donate.
Transplantation proceedings 2005;37(5):2011-5.
2005: Schuetz M; Einecke G; Mai I; Neumayer H-H; Glander P; Waiser J; Fritsche L; Budde K
Problems of cyclosporine absorption profiling using C2-monitoring.
European journal of medical research 2005;10(4):175-8.
2005: Budde K; Fritsche L; Waiser J; Glander P; Slowinski T; Neumayer H-H;
Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patients.
European journal of medical research 2005;10(4):169-74.
2005: Krämer B K; Neumayer H-H; Stahl R; Pietrzyk M; Krüger B; Pfalzer B; Bourbigot B; Campbell S; Whelchel J; Eris J; Vitko S; Budde K;
Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab.
Transplantation proceedings 2005;37(3):1601-4.
2005: Bräsen Jan Hinrich; Nieminen-Kelhä Melina; Markmann Denise; Malle Ernst; Schneider Wolfgang; Neumayer Hans-Hellmut; Budde Klemens; Luft Friedrich C; Dragun Duska
Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1)-mediated pathway and vascular oxidative injury in older-age rat renal transplants.
Kidney international 2005;67(4):1583-94.
2005: Budde Klemens; Fritsche Lutz
Proposal for guidelines for publication of randomized trials in the American Journal of Transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(4 Pt 1):644-7.
2005: Budde K; Knoll G; Curtis J; Kahana L; Pohanka E; Seifu Y; Neumayer H H
Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.
Transplantation proceedings 2005;37(2):912-5.
2005: Fritsche L; Hoerstrup J; Budde K; Reinke P; Neumayer H-H; Frei U; Schlaefer A
Accurate prediction of kidney allograft outcome based on creatinine course in the first 6 months posttransplant.
Transplantation proceedings 2005;37(2):731-3.
2005: Böhler Torsten; Budde Klemens; Neumayer Hans-H; Waiser Johannes
Novel mediators of FTY720 in human lymphocytes.
Transplantation 2005;79(4):492-5.
2005: Dragun Duska; Müller Dominik N; Bräsen Jan Hinrich; Fritsche Lutz; Nieminen-Kelhä Melina; Dechend Ralf; Kintscher Ulrich; Rudolph Birgit; Hoebeke Johan; Eckert Diana; Mazak Istvan; Plehm Ralph; Schönemann Constanze; Unger Thomas; Budde Klemens; Neumayer Hans-Hellmut; Luft Friedrich C; Wallukat Gerd
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
The New England journal of medicine 2005;352(6):558-69.
2005: Gaedeke Jens; Boehler Torsten; Budde Klemens; Neumayer Hans-H; Peters Harm
Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(2):319-28.
2005: Schmook Tobias; Budde Klemens; Ulrich Claas; Neumayer Hans-Hellmut; Fritsche Lutz; Stockfleth Eggert
Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(1):220-2.
2004: Glander Petra; Hambach Pia; Braun Kay-Patrick; Fritsche Lutz; Giessing Markus; Mai Ingnid; Einecke Gunilla; Waiser Johannes; Neumayer Hans-Hellmut; Budde Klemens
Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(12):2045-51.
2004: Mai Ingrid; Perloff Elke S; Bauer Steffen; Goldammer Mark; Johne Andreas; Filler Guido; Budde Klemens; Roots Ivar
MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients.
British journal of clinical pharmacology 2004;58(5):548-53.
2004: Diekmann Fritz; Budde Klemens; Oppenheimer Federico; Fritsche Lutz; Neumayer Hans H; Campistol Josep M
Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(11):1869-75.
2004: Slowinski Torsten; Diehr Petra; Kleemann Patrick; Fritsche Lutz; Renders Lutz; Budde Klemens; Hauser Ingeborg A; Neumayer Hans H; Hocher Berthold
No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(11):2846-51.
2004: Mai Ingrid; Bauer Steffen; Perloff Elke S; Johne Andreas; Uehleke Bernhard; Frank Bruno; Budde Klemens; Roots Ivar
Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.
Clinical pharmacology and therapeutics 2004;76(4):330-40.
2004: Budde Klemens; Neumayer Hans-Hellmut; Lehne Gustav; Winkler Michael; Hauser Ingeborg Anni; Lison Arno; Fritsche Lutz; Soulillou Jean-Paul; Fauchald Per; Dantal Jaques;
Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(10):2606-14.
2004: Giessing Markus; Reuter Stefan; Schönberger Bernd; Deger Serdar; Tuerk Ingolf; Hirte Ingrid; Budde K; Fritsche L; Morgera Stanislao; Neumayer H H; Loening S A
Quality of life of living kidney donors in Germany: a survey with the Validated Short Form-36 and Giessen Subjective Complaints List-24 questionnaires.
Transplantation 2004;78(6):864-72.
2004: Giessing M; Conrad S; Schönberger B; Huland H; Budde K; Neumayer H-H; Loening S A
[Kidney donors and kidney transplantation in the elderly]
Der Urologe. Ausg. A 2004;43(8):947-54.
2004: Budde Klemens; Glander Petra; Diekmann Fritz; Waiser Johannes; Fritsche Lutz; Dragun Duska; Neumayer Hans-Hellmut
Review of the immunosuppressant enteric-coated mycophenolate sodium.
Expert opinion on pharmacotherapy 2004;5(6):1333-45.
2004: Böhler Torsten; Waiser Johannes; Schütz Manuela; Dragun Duska; Neumayer Hans-H; Budde Klemens
FTY720 mediates apoptosis-independent lymphopenia in human renal allograft recipients: different effects on CD62L+ and CCR5+ T lymphocytes.
Transplantation 2004;77(9):1424-32.
2004: Liefeldt Lutz; van Giersbergen Paul L M; Dingemanse Jasper; Rudolph Birgit; Walde Torsten; Budde Klemens; Neumayer Hans-H; Hocher Berthold
Treatment of secondary pulmonary hypertension with bosentan and its pharmacokinetic monitoring in ESRD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(5):923-6.
2004: Fritsche Lutz; Einecke Gunilla; Fleiner Franca; Dragun Duska; Neumayer Hans-Hellmut; Budde Klemens
Reports of large immunosuppression trials in kidney transplantation: room for improvement.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(5):738-43.
2004: Dragun D; Fritsche L; Boehler T; Peters H; Budde K; Neumayer H H
FTY720: early clinical experience.
Transplantation proceedings 2004;36(2 Suppl):544S-548S.
2004: Budde K; Glander P; Diekmann F; Dragun D; Waiser J; Fritsche L; Neumayer H-H
Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
Transplantation proceedings 2004;36(2 Suppl):524S-527S.
2004: Fritsche L; Dragun D; Neumayer H H; Budde K
Impact of cyclosporine on the development of immunosuppressive therapy.
Transplantation proceedings 2004;36(2 Suppl):130S-134S.
2004: Dragun Duska; Böhler Torsten; Nieminen-Kelhä Melina; Waiser Johannes; Schneider Wolfgang; Haller Hermann; Luft Friedrich C; Budde Klemens; Neumayer Hans-Hellmut
FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.
Kidney international 2004;65(3):1076-83.
2004: Böhler Torsten; Waiser Johannes; Schuetz Manuela; Neumayer Hans H; Budde Klemens
FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(3):702-13.
2004: Budde Klemens; Curtis John; Knoll Gregory; Chan Lawrence; Neumayer Hans-Hellmut; Seifu Yodit; Hall Michael;
Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(2):237-43.
2004: Giessing M; Schönberger B; Fritsche L; Budde K
[Evaluation and follow-up of living kidney donors]
Deutsche medizinische Wochenschrift (1946) 2004;129(4):147-50.
2004: Fritsche Lutz; Budde Klemens; Dragun Duska; Einecke Gunilla; Diekmann Fritz; Neumayer Hans-Hellmut
Testosterone concentrations and sirolimus in male renal transplant patients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(1):130-1.
2004: Einecke Gunilla; Mai Ingrid; Fritsche Lutz; Slowinski Torsten; Waiser Johannes; Neumayer Hans-Hellmut; Budde Klemens
The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(1):215-22.
2004: Diekmann Fritz; Fritsche Lutz; Neumayer Hans-Hellmut; Budde Klemens
Sirolimus dosage during and after conversion from calcineurin inhibitor therapy to sirolimus in chronic kidney transplant patients.
Kidney & blood pressure research 2004;27(3):186-90.
2003: Giessing M; Slowinski T; Deger S; Tuerk I; Schönberger S; Budde K; Loening S A
Living donor nephrectomy--no impact of genetic relationship.
Transplantation proceedings 2003;35(8):2860-2.
2003: Giessing M; Slowinski T; Deger S; Tuerk I; Schönberger S; Budde K; Loening S A
20-year experience with elderly donors in living renal transplantation.
Transplantation proceedings 2003;35(8):2855-7.
2003: Waiser Johannes; Böhler Torsten; Stoll Juliane; Schumann Brit; Budde Klemens; Neumayer Hans-Hellmut
The immunosuppressive potential of misoprostol--efficacy and variability.
Clinical immunology (Orlando, Fla.) 2003;109(3):288-94.
2003: Giessing Markus; Budde Klemens; Fritsche Lutz; Slowinski Torsten; Tuerk Ingolf; Schoenberger Bernd; Neumayer Hans-Helmut; Loening Stefan A
"Old-for-old" cadaveric renal transplantation: surgical findings, perioperative complications and outcome.
European urology 2003;44(6):701-8.
2003: Fritsche L; Budde K; Glander P; Einecke G; Diekmann F; Schötschel R; Neumayer H H
Treating type 2 diabetes in renal insufficiency: the role of pioglitazone.
International journal of clinical pharmacology and therapeutics 2003;41(10):488-91.
2003: Böhler T; Waiser J; Schütz M; Schumann B; Neumayer H H; Budde K
Pharmacodynamics of FTY720, the first member of a new class of immune-modulating therapeutics in transplantation medicine.
International journal of clinical pharmacology and therapeutics 2003;41(10):482-7.
2003: Einecke G; Mai I; Fritsche L; Slowinski T; Waiser J; Glander P; Böhler T; Neumayer H H; Budde K
Cyclosporin C2hour monitoring after renal transplantation.
International journal of clinical pharmacology and therapeutics 2003;41(10):477-81.
2003: Glander P; Hambach P; Braun K P; Fritsche L; Waiser J; Mai I; Neumayer H H; Budde K
Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.
International journal of clinical pharmacology and therapeutics 2003;41(10):470-6.
2003: Mai Ingrid; Störmer Elke; Goldammer Mark; Johne Andreas; Krüger Hagen; Budde Klemens; Roots Ivar
MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patients.
Journal of clinical pharmacology 2003;43(10):1101-7.
2003: Dragun D; Bräsen J H; Schönemann C; Fritsche L; Budde K; Neumayer H-H; Luft F C; Wallukat G
Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor.
Transplantation proceedings 2003;35(6):2104-5.
2003: Giessing Markus; Kroencke Thomas J; Taupitz Matthias; Feldmann Claudia; Deger Serdar; Turk Ingolf; Budde Klemens; Ebeling Volko; Schoenberger Bernd; Loening Stefan A
Gadolinium-enhanced three-dimensional magnetic resonance angiography versus conventional digital subtraction angiography: which modality is superior in evaluating living kidney donors?
Transplantation 2003;76(6):1000-2.
2003: Budde Klemens; L Schmouder Robert; Nashan Bjorn; Brunkhorst Reinhard; W Lücker Peter; Mayer Thomas; Brookman Laurence; Nedelman Jerry; Skerjanec Andrej; Böhler Torsten; Neumayer Hans-Hellmut
Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(7):846-54.
2003: Dell Kerstin; Böhler Torsten; Gaedeke Jens; Budde Klemens; Neumayer Hans-Hellmut; Waiser Johannes
Impact of PGE1 on cyclosporine A induced up-regulation of TGF-beta1, its receptors, and related matrix production in cultured mesangial cells.
Cytokine 2003;22(6):189-93.
2003: Fritsche L; Budde K; Neumayer H-H
[Treatment of hypercholesterolemia in kidney transplant recipients]
Deutsche medizinische Wochenschrift (1946) 2003;128(16):879-81.
2003: Budde Klemens; Neumayer Hans-Hellmut; Fritsche Lutz; Sulowicz Wladyslaw; Stompôr Tomasz; Eckland David
The pharmacokinetics of pioglitazone in patients with impaired renal function.
British journal of clinical pharmacology 2003;55(4):368-74.
2003: Mai Ingrid; Störmer Elke; Bauer Steffen; Krüger Hagen; Budde Klemens; Roots Ivar
Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(4):819-22.
2003: Bauer Steffen; Störmer Elke; Johne Andreas; Krüger Hagen; Budde Klemens; Neumayer Hans-Hellmut; Roots Ivar; Mai Ingrid
Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients.
British journal of clinical pharmacology 2003;55(2):203-11.
2002: Giessing M; Deger S; Turk I; Schönberger B; Budde K; Loening S A
Laparoscopic donor nephrectomy in Germany.
Transplantation proceedings 2002;34(8):3099-101.
2002: Boehler T; Schuetz M; Budde K; Neumayer H; Waiser J
FTY720 alters the composition of T-lymphocyte subpopulations in the peripheral blood compartment of renal transplant patients.
Transplantation proceedings 2002;34(6):2242-3.
2002: Schönberger B; Giessing M; Vogler H; Budde K; Loening S
Relevance and meaning of prostate cancer in kidney transplantation.
Transplantation proceedings 2002;34(6):2225-6.
2002: Fritsche Lutz; Schlaefer Alexander; Budde Klemens; Schroeter Kay; Neumayer Hans-Hellmut
Recognition of critical situations from time series of laboratory results by case-based reasoning.
Journal of the American Medical Informatics Association : JAMIA 2002;9(5):520-8.
2002: Waiser Johannes; Dell Kerstin; Böhler Torsten; Dogu Ertan; Gaedeke Jens; Budde Klemens; Neumayer Hans-Hellmut
Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(9):1568-77.
2002: Giessing M; Fischer T J; Deger S; Türk I; Schönberger B; Fritsche L; Neumayer H H; Loening S A; Budde K
Increased frequency of lymphoceles under treatment with sirolimus following renal transplantation: a single center experience.
Transplantation proceedings 2002;34(5):1815-6.
2002: Budde K; Braun K-P; Glander P; Böhler T; Hambach P; Fritsche L; Waiser J; Mai I; Neumayer H-H
Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients.
Transplantation proceedings 2002;34(5):1748-50.
2002: Braun K-P; Glander P; Hambach P; Böhler T; Waiser J; Mai I; Neumayer H-H; Budde K
Pharmacokinetics and pharmacodynamics of mycophenolate mofetil under oral and intravenous therapy.
Transplantation proceedings 2002;34(5):1745-7.
2002: Einecke G; Mai I; Diekmann F; Fritsche L; Neumayer H-H; Budde K
Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipients.
Transplantation proceedings 2002;34(5):1738-9.
2002: Budde K; Geissler S; Hallebach G; Waiser J; Fritsche L; Böhler T; Neumayer H-H
Prospective randomized pilot study of steroid withdrawal with mycophenolate mofetil in long-term cyclosporine-treated patients: 4-year follow-up.
Transplantation proceedings 2002;34(5):1703-5.
2002: Budde K; Hallebach G; Geissler S; Fritsche L; Diekmann F; Waiser J; Neumayer H H
Successful steroid withdrawal at the end of the 1st year after renal transplantion in mycophenolate mofetil-treated patients.
Transplantation proceedings 2002;34(5):1700-2.
2002: Budde K; Smettan S; Fritsche L; Waiser J; Neumayer H-H
Five year outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
Transplantation proceedings 2002;34(5):1594-6.
2002: Waiser Johannes; Slowinski Torsten; Brinker-Paschke Andrea; Budde Klemens; Schreiber Matthias; Böhler Torsten; Hauser Ingeborg; Neumayer Hans-Hellmut
Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(7):1310-7.
2002: Waiser Johannes; Schwaar Stefan; Böhler Torsten; Rudolph Birgit; Dell Kerstin; Budde Klemens; Dietel Manfred; Neumayer Hans-Hellmut
Immunohistochemical double-staining of renal allograft tissue: critical assessment of three different protocols.
Virchows Archiv : an international journal of pathology 2002;440(6):648-54.
2002: Budde Klemens; Schmouder Robert L; Brunkhorst Reinhard; Nashan Bjorn; Lücker Peter W; Mayer Thomas; Choudhury Somesh; Skerjanec Andrej; Kraus Gerolf; Neumayer Hans H
First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients.
Journal of the American Society of Nephrology : JASN 2002;13(4):1073-83.
2002: Fritsche Lutz; Hoerstrup Jan; Budde Klemens; Frei Ulrich; Kahl Andreas; Loening Stefan; May Gottfried; Neuhaus Peter; Neumayer Hans-Hellmut; Reinke Petra; Schoenberger Bernd; Schoenemann Constanze
Kidney transplantation at the Charité: long tradition, elderly patients and the duration of hospitalization.
Clinical transplants 2002;():171-9.
2001: Giessing M; Türk I; Deger S; Schönberger S; Budde K; Loening S A
Laparoscopic kidney harvesting for living donor kidney transplantation--one year follow-up of the initial 15 patients.
Transplantation proceedings 2001;33(7-8):3791-2.
2001: Dell K; Böhler T; Gaedeke J; Budde K; Neumayer H H; Waiser J
Prostaglandin E(1) inhibits cyclosporine A-induced upregulation of transforming growth factor-beta 1 in rat mesangial cells.
Transplantation proceedings 2001;33(7-8):3342-4.
2001: Fritsche L; Schlaefer A; Budde K; Schroeter K; Neumayer H H
Case-based reasoning algorithm for kidney transplant monitoring.
Transplantation proceedings 2001;33(7-8):3331-3.
2001: Budde K; Glander P; Braun K P; Böhler T; Waiser J; Fritsche L; Mai I; Neumayer H
Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients.
Transplantation proceedings 2001;33(7-8):3313-5.
2001: Budde K; Fritsche L; Geissler S; Hallebach G; Diekmann F; Mai I; Böhler T; Waiser J; Neumayer H H
Steroid withdrawal in long-term cyclosporine A treated patients using mycophenolate mofetil: a prospective randomized pilot study.
Transplantation proceedings 2001;33(7-8):3250-2.
2001: Diekmann F; Waiser J; Fritsche L; Dragun D; Neumayer H H; Budde K
Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity.
Transplantation proceedings 2001;33(7-8):3234-5.
2001: Böhler T; Budde K; Schneider M; Eliazyfer S; Dell K; Einecke G; Diekmann F; Fritsche L; Mai I; Neumayer H H; Waiser J
Pharmacodynamic monitoring of lymphocyte proliferation and TGF-beta 1 expression at cyclosporine a (CyA) trough levels (C(0)) and 2 hours after intake (C(2)) of CyA in human renal allograft recipients.
Transplantation proceedings 2001;33(7-8):3148-50.
2001: Einecke G; Mai I; Diekmann F; Fritsche L; Boehler T; Neumayer H H; Budde K
Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(0)) and C(2) concentrations in stable renal allograft recipients.
Transplantation proceedings 2001;33(7-8):3102-3.
2001: Glander P; Braun K P; Hambach P; Bauer S; Mai I; Roots I; Waiser J; Fritsche L; Neumayer H H; Budde K
Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.
Clinical biochemistry 2001;34(7):543-9.
2000: Budde K; Glander P; Bauer S; Braun K; Waiser J; Fritsche L; Mai I; Roots I; Neumayer H H
Pharmacodynamic monitoring of mycophenolate mofetil.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2000;38(11):1213-6.
2000: Fritsche L; Vanrenterghem Y; Nordal K P; Grinyo J M; Moreso F; Budde K; Kunz R; Meyerrose B; Neumayer H H
Practice variations in the evaluation of adult candidates for cadaveric kidney transplantation: a survey of the European Transplant Centers.
Transplantation 2000;70(10):1492-7.
2000: Mai I; Krüger H; Budde K; Johne A; Brockmöller J; Neumayer H H; Roots I
Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin.
International journal of clinical pharmacology and therapeutics 2000;38(10):500-2.
2000: Böhler T; Waiser J; Hepburn H; Gaedeke J; Lehmann C; Hambach P; Budde K; Neumayer H H
TNF-alpha and IL-1alpha induce apoptosis in subconfluent rat mesangial cells. Evidence for the involvement of hydrogen peroxide and lipid peroxidation as second messengers.
Cytokine 2000;12(7):986-91.
2000: Waiser J; Schreiber M; Budde K; Fritsche L; Böhler T; Hauser I; Neumayer H H
Age-matching in renal transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(5):696-700.
2000: Waiser J; Schötschel R; Budde K; Neumayer H H
Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;35(3):E12.
2000: Böhler T; Waiser J; Schütz M; Friedrich M; Schötschel R; Reinhold S; Schmouder R; Budde K; Neumayer H H
FTY 720A mediates reduction of lymphocyte counts in human renal allograft recipients by an apoptosis-independent mechanism.
Transplant international : official journal of the European Society for Organ Transplantation 2000;13 Suppl 1():S311-3.
2000: Fritsche L; Nordal K P; Vanrenterghem Y; Grinyo J M; Moreso F; Budde K; Neumayer H H
Different diagnostic approaches to adult candidates for cadaveric kidney transplantation in Europe.
Transplant international : official journal of the European Society for Organ Transplantation 2000;13 Suppl 1():S263-6.
2000: Waiser J; Schreiber M; Budde K; Böhler T; Kraus W; Hauser I; Riess R; Neumayer H H
Prognostic value of the Banff classification.
Transplant international : official journal of the European Society for Organ Transplantation 2000;13 Suppl 1():S106-11.
1999: Morgera S; Kuchinke S; Budde K; Lun A; Hocher B; Neumayer H H
Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysis.
Journal of the American Society of Nephrology : JASN 1999;10(12):2585-90.
1999: Neumayer H H; Paradis K; Korn A; Jean C; Fritsche L; Budde K; Winkler M; Kliem V; Pichlmayr R; Hauser I A; Burkhardt K; Lison A E; Barndt I; Appel-Dingemanse S
Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients.
British journal of clinical pharmacology 1999;48(5):694-703.
1999: Waiser J; Budde K; Braasch E; Neumayer H H
Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(3):e9.
1999: Waiser J; Budde K; Rudolph B; Ortner M A; Neumayer H H
De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(3):556-9.
1999: Fritsche L; Budde K; Färber L; Charissé G; Kunz R; Gaedeke J; Neumayer H H
Treatment of membranous glomerulopathy with cyclosporin A: how much patience is required?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(4):1036-8.
1999: Dogu E; Waiser J; Böhler T; Budde K; Rudolph B; Neumayer H H
Renal failure from diabetic glomerulosclerosis three decades after allograft transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(4):974-6.
1999: Mück W; Mai I; Fritsche L; Ochmann K; Rohde G; Unger S; Johne A; Bauer S; Budde K; Roots I; Neumayer H H; Kuhlmann J
Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients.
Clinical pharmacology and therapeutics 1999;65(3):251-61.
1999: Meisel H; Reip A; Krüger D H; Budde K; Fritsche L; Neumayer H H
Long-term investigation of hepatitis G virus infection in renal transplant recipients with and without hepatitis B and C co-infection.
Transplantation proceedings 1999;31(1-2):1382-3.
1999: Meisel H; Preikschat P; Reinke P; Hocher B; Budde K; Bechstein W O; Neuhaus P; Krüger D H; Neumayer H H
Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
Transplant international : official journal of the European Society for Organ Transplantation 1999;12(4):283-7.
1998: Fritsche L; Sperschneider H; Budde K; Giessing M; Türk H; Böhler T; Schröder K; Stein G; Neumayer H H
Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.
Transplantation proceedings 1998;30(5):2229.
1998: Böhler T; Waiser J; Budde K; Lichter S; Jauho A; Fritsche L; Korn A; Neumayer H H
The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.
Transplantation proceedings 1998;30(5):2195-7.
1998: Waiser J; Budde K; Schreiber M; Korn K; Stenglein S; Drenckhahn J T; Böhler T; Hauser I; Neumayer H H
Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease.
Transplantation proceedings 1998;30(5):2083-5.
1998: Budde K; Smettan S; Fritsche L; Waiser J; Giessing M; Kunz R; Türk I; Bauer S; Mai I; Neumayer H H
Long-term outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
Transplantation proceedings 1998;30(5):1780-1.
1998: Waiser J; Budde K; Schreiber M; Böhler T; Löbermann L A; Neumayer H H
Antibody therapy in steroid-resistant rejection.
Transplantation proceedings 1998;30(5):1778-9.
1998: Budde K; Fritsche L; Smettan S; Schönberger B; Loening S A; Mai I; Bauer S; Waiser J; Neumayer H H
Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months.
Transplantation proceedings 1998;30(4):1238-9.
1998: Morgera S; Neumayer H H; Fritsche L; Kuchinke S; Lampe D; Ahnert V; Bauer S; Mai I; Budde K
Pharmacokinetics of mycophenolate mofetil in renal transplant recipients on peritoneal dialysis.
International journal of clinical pharmacology and therapeutics 1998;36(3):159-63.
1998: Waiser J; Budde K; Schreiber M; Peibst O; Koch U; Böhler T; Höffken B; Hauser I; Neumayer H H
The quality of life in end stage renal disease care.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11 Suppl 1():S42-5.
1998: Morgera S; Budde K; Lampe D; Ahnert V; Fritsche L; Kuchinke S; Neumayer H H
Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysis.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11(1):53-7.
1997: Budde K; Neumayer H H; Salant D J; Cybulsky A V; Coleman D L; Sterzel R B
Glomerular epithelial cell products stimulate mesangial cell proliferation in culture.
Kidney international 1997;52(3):733-41.
1997: Budde K; Waiser J; Ceska M; Katalinic A; Kürzdörfer M; Neumayer H H
Interleukin-8 expression in patients after renal transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(6):871-80.
1997: Budde K; Waiser J; Fritsche L; Zitzmann J; Schreiber M; Kunz R; Neumayer H H
Hypertension in patients after renal transplantation.
Transplantation proceedings 1997;29(1-2):209-11.
1997: Budde K; Fritsche L; Neumayer H H
Differing proteinuria control with cyclosporin and tacrolimus.
Lancet 1997;349(9048):330.
1997: Waiser J; Budde K; Böhler T; Neumayer H H
The influence of age on outcome after renal transplantation.
Geriatric nephrology and urology 1997;7(3):137-46.
1996: Budde K; Fritsche L; Mai I; Bauer S; Smettan S; Waiser J; Hofmann T; Hauser I; Reinke P; Neumayer H H
Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation.
International journal of clinical pharmacology and therapeutics 1996;34(11):493-7.
1996: Neumayer H H; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft F C
Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
Transplantation proceedings 1996;28(4):2207-13.
1996: Neumayer H H; Budde K; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft F C
Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
Clinical nephrology 1996;45(5):326-31.
1996: Neumayer H H; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Budde K; Waiser J; Luft F C
Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(1):165-72.
1994: Budde K; Waiser J; Neumayer H H
The diagnostic value of GM-CSF and IL-6 determinations in patients after renal transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S97-101.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Klemens Budde

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Klemens Budde (preview)

All Publications